Choreo LLC’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Sell
6,232
-1,171
-16% -$243K 0.02% 502
2026
Q1
$1.56M Buy
7,403
+284
+4% +$61.2K 0.02% 469
2025
Q4
$1.48M Buy
7,119
+560
+9% +$105K 0.02% 461
2025
Q3
$1.03M Sell
6,559
-207
-3% -$32K 0.01% 590
2025
Q2
$1.14M Buy
6,766
+1,181
+21% +$175K 0.02% 542
2025
Q1
$769K Sell
5,585
-1,247
-18% -$159K 0.01% 652
2024
Q4
$806K Sell
6,832
-74
-1% -$8.64K 0.01% 664
2024
Q3
$765K Buy
6,906
+700
+11% +$73.2K 0.01% 689
2024
Q2
$607K Buy
+6,206
New +$632K 0.01% 728

Other funds holding CAH

Choreo LLC's CAH Position: Q2 2026 in Review

Choreo LLC reduced its Cardinal Health (CAH) stake by 16% in Q2 2026, selling an estimated $243K and leaving 6,232 shares worth $1.48M. The position accounts for 0.02% of the portfolio, ranked #502.

Choreo LLC first reported a position in CAH in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.56M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Choreo LLC held 6,232 shares of Cardinal Health worth $1.48M as of Q2 2026.
  • Choreo LLC sold 1,171 Cardinal Health shares in Q2 2026, an estimated $243K.
  • Cardinal Health made up 0.02% of Choreo LLC's portfolio in Q2 2026, its #502 holding.
  • Choreo LLC first reported a position in Cardinal Health in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's Cardinal Health position peaked at $1.56M in Q1 2026.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.